ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 140 filers reported holding ACCELERON PHARMA INC in Q1 2017. The put-call ratio across all filers is 2.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,159,000 | +63.7% | 8,543 | -36.0% | 0.19% | +134.1% |
| Q4 2019 | $708,000 | +198.7% | 13,357 | +162.7% | 0.08% | +241.7% |
| Q1 2019 | $237,000 | -84.2% | 5,085 | -87.3% | 0.02% | -76.5% |
| Q3 2017 | $1,496,000 | -33.1% | 40,099 | -52.5% | 0.10% | -15.0% |
| Q1 2017 | $2,237,000 | – | 84,500 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |